September 30 - October 3, 2026, Vienna, Austria

European Academy of Dermatology and Venereology (EADV)

Poster icon

Ethnic differences in the autoantibody profile of patients with chronic spontaneous urticaria

Sarbjit Saini, Martin Metz, Michihiro Hide, Theodoulos Rodosthenous, Alexandre Avrameas, Christoph Kollenda-Strunk, Ann-Sophie Lindemann, Annika LoredanaKilian, Petra Budde, Manuel Bräutigam, Hans-Dieter Zucht, Bruno Cenni, Ulf Gehrmann, Nadine Chapman-Rothe, Sibylle Haemmerle
e-Poster
Poster icon

Continued improvement of quality of life with remibrutinib in patients with chronic spontaneous urticaria from the 24 week-long randomized withdrawal period of REMIXED extension study

Martin Metz, Ana Giménez-Arnau, Koremasa Hayama, Michihiro Hide, Vipul Jain, Kanokvalai Kulthanan, Wei Lai, Mark Lebwohl, Undine Lippert, Giselle Mosnaim, Michael Palumbo, Bin Yang, Young Min Ye, Swapnil Dahale, Clarice Field, Sibylle Haemmerle, Lukasz Jaskiewicz, Karine Lheritier, Luna Wei, Sarbjit Saini
e-Poster
Poster icon

Remibrutinib provides fast symptom relief within the first week of treatment in chronic spontaneous urticaria, as measured by daily Urticaria Activity Score: Pooled REMIX-1/-2 studies

Hugh Windom, Paula Machado, Christine-Elke Ortmann, Nadine Chapman-Rothe, Tao Ding, Mark Lebwohl, Ansgar Weyergraf, Hui Tang, Michihiro Hide, John Reed
e-Poster
Poster icon

REASSERT: A global, prospective, non-interventional study evaluating the real-world effectiveness and safety of remibrutinib in adults with chronic spontaneous urticaria

Ana Giménez-Arnau, Atsushi Fukunaga, April Armstrong, Martin Metz, Romi Saini, Koremasa Hayama, Iftekhar Khan, Tara Raftery, Nadine Chapman-Rothe, Zuotao Zhao
e-Poster
Poster icon

Limited effectiveness of current therapies in chronic inducible urticaria: Insights from the Chronic Urticaria Registry (CURE)

Pavel Kolkhir, Twinkle Budhrani, Yana Hackler, Pascale Salameh, Leonie Shirin Herzog, Felix Aulenbacher, Simon Francis Thomsen, Nicole Nojarov, Jonny G. Peter, Mojca Bizjak-Suran, Emek Kocatürk, Nadine Chapman-Rothe, Tara Raftery, Riccardo Asero, Clive Grattan, Magdalena Zajac, Alicja Kasperska-Zajac, Ana M. Giménez-Arnau, Karsten Weller
e-Poster
Poster icon

Treatment patterns of patients with chronic urticaria before and after referral to specialized care: a nationwide Danish cohort study

Jennifer Astrup Sørensen, Nana Aviaaja Lippert Rosenø, Mia-Louise Nielsen, Somaia Naassan, Martin Metz, Manuel P. Pereira, Emek Kocatürk, Pavel Kolkhir, Christian Vestergaard, Alexander Egeberg, Jacob P. Thyssen, Panagiotis Orfanos, Nadine Chapman-Rothe, Tara Raftery, Zarqa Ali, Simon Francis Thomsen
e-Poster
Poster icon

Baseline assessment of chronic spontaneous urticaria management in German outpatient care: Preimplementation results from the BRIDGE study

Sebastian Volc, Nicola Wagner, Ferenc Kiss, Laura Dawkins, Eva Schruf, Martin Metz
e-Poster
Poster icon

Defining disease burden and unmet needs among patients with chronic spontaneous urticaria in Belgium

Niels T. Hilhorst, L. Noortman, K. Allewaert
e-Poster
Poster icon

Patient perspectives on disease burden, symptoms, and comorbidities: Findings from the Urticaria Voices China study in patients with chronic spontaneous urticaria

Bin Yang, Li Yi, Pallavi Saraswat, Tara Raftery, Nadine Chapman-Rothe, Cristina Constantinescu, Ruxin Tan, Zuotao Zhao
e-Poster
Poster icon

Urticaria Voices China study: Patient self-reported treatment patterns associated with chronic spontaneous urticaria

Bin Yang, Li Yi, Pallavi Saraswat, Tara Raftery, Nadine Chapman-Rothe, Cristina Constantinescu, Ruxin Tan, Zuotao Zhao
e-Poster
Poster icon

The Urticaria Care Package and its role in improving chronic spontaneous urticaria management: Findings from the BRIDGE implementation study

Piergiacomo Calzavara-Pinton, Riccardo Asero, Pallavi Saraswat, Nadine Chapman-Rothe, Abigail Herbst, Bridget Gaglio, Fabio Speranza, Ornella Bonavita, Tara Raftery, Enrico Iemoli
e-Poster
Poster icon

Remibrutinib decreases specific IgG autoantibody levels in patients with Chronic Spontaneous Urticaria

Martin Metz, Sarbjit Saini, Michihiro Hide, Theodoulos Rodosthenous, Alexandre Avrameas, Elham Jones, Anita Auger-Sarrazin, Jianping Yuan, Christoph Kollenda-Strunk, Ann-Sophie Lindemann, Annika Loredana Kilian, Petra Budde, Manuel Bräutigam, Hans-Dieter Zucht, Bruno Cenni, Ulf Gehrmann, Nadine Chapman-Rothe, Sibylle Haemmerle
Oral Presentation
Poster icon

Remibrutinib-treated patients with CSU who achieve well-controlled disease activity reach this by week 3 in the majority of patients: Results from REMIX-1/-2 studies

Martin Metz, Michihiro Hide, Wei Lai, Sibylle Haemmerle, Nadine Chapman-Rothe, Christine-Elke Ortmann, Giselle Mosnaim
Oral Presentation e-Poster
Poster icon

Efficacy of remibrutinib in patients with CSU by demographics and baseline characteristics: Pooled analysis from REMIX-1 and REMIX-2 studies

Sarbjit Saini, Atsushi Fukunaga, Bin Yang, Sibylle Haemmerle, El-Djouher Martzloff, Christine-Elke Ortmann, Karine Lheritier, Vipul Jain
Oral Presentation e-Poster
Poster icon

REMIX-1/-2: Long-term efficacy of remibrutinib in patients with CSU from the European region

Ana M. Gimenez-Arnau, Knut Brockow, Ansgar Weyergraf, Abdallah Khemis, Christine-Elke Ortmann, Noriko Seko, Pengpeng Wang, Sibylle Haemmerle, Irena Walecka Herniczek
e-Poster
Poster icon

Patient journey and disease burden in chronic inducible urticaria (CIndU): Analysis from the Urticaria Voices study

Sabine Altrichter, Giselle Mosnaim, Jonathan A. Bernstein, Tonya A. Winders, Jessica McCarthy, Pallavi Saraswat, Nadine Chapman-Rothe, Tara Raftery, Karsten Weller
e-Poster
Poster icon

Status update of chronic spontaneous urticaria management and knowledge among Italian General Practitioners: BRIDGE Implementation Science study

Piergiacomo Calzavara Pinton, Riccardo Asero, Nadine Chapman-Rothe, Pallavi Saraswat, Vinodh Nallasamy, Abigail Herbst, Bridget Gaglio, Fabio Speranza, Ornella Bonavita, Tara Raftery, Enrico Iemoli
e-Poster
Poster icon

Impact of early vs late biologic treatment initiation on health care resource utilization in patients with chronic spontaneous urticaria: Results from a United States Claims Database Study

Gil Yosipovitch, Dhaval Patil, Merin Kuruvilla, Jason Doran, Irina Pivneva, Frédéric Kinkead, Panagiotis Orfanos, Tara Raftery, Marc A. Riedl
Oral Presentation e-Poster
Poster icon

Variation in CSU management practices between dermatology and immunology/allergy – Results from the REVEAL UK survey

Kashif Bhatti, Michael R Ardern-Jones, Susana Marinho, Tariq El-Shanawany, Suzanne Pilkington, Lauren Bateman, Joe Foggin, Chris Ioannou, Grace Fowler
e-Poster
Poster icon

Epidemiology, clinical characteristics and treatment patterns of chronic spontaneous urticaria patients treated in Finnish secondary care: A register-based study

Emma Heikkinen, Jari Jokelainen, Laura Huilaja, Suvi-Päivikki Sinikumpu, Maija Wolf
e-Poster
Poster icon

Burden of illness in chronic inducible urticaria (CIndU): A targeted literature review (TLR)

Samprati Avasthi, Ravneet Kaur Kohli, Panagiotis Orfanos
e-Poster
Novartis logo
FA-11248855-1     08/26
© Copyright 2026 Novartis Pharma AG